Stock Research: Astellas Pharma

Independent stock analysis through peer comparison: Get the 360° View as an objective basis for stock decision-making and explore the detailed ranks.

Astellas Pharma

TYO:4503 JP3942400007
93
  • Value
    96
  • Growth
    90
  • Safety
    Safety
    50
  • Combined
    92
  • Sentiment
    55
  • 360° View
    360° View
    93
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

Astellas Pharma Inc. is a Japan-based pharmaceutical company focused on the research, development, manufacture, and sale of pharmaceutical products. The company operates in the pharmaceutical industry, with products including XTANDI, BETANIS, and MIRABETRIC. Astellas Pharma Inc. primarily operates in Japan. In the last fiscal year, the company had a market cap of $17,488 million, profits of $10,424 million, and revenue of $12,753 million, with 13,643 employees.

more
Index
TOPIX 100
Nikkei 225
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 27-Feb-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
96 70 66 67
Growth
90 49 19 89
Safety
Safety
50 10 39 39
Sentiment
55 16 6 14
360° View
360° View
93 21 12 55
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
4 30 50 65
Opinions Change
66 23 15 50
Pro Holdings
n/a 40 16 18
Market Pulse
19 26 9 17
Sentiment
55 16 6 14
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
96 70 66 67
Growth
90 49 19 89
Safety Safety
50 10 39 39
Combined
92 35 33 76
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
56 74 59 50
Price vs. Earnings (P/E)
76 42 58 80
Price vs. Book (P/B)
58 41 45 53
Dividend Yield
100 96 91 92
Value
96 70 66 67
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
44 18 58 47
Profit Growth
99 67 55 79
Capital Growth
76 71 4 54
Stock Returns
80 42 27 85
Growth
90 49 19 89
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
32 17 59 48
Refinancing
27 4 7 21
Liquidity
90 34 72 72
Safety Safety
50 10 39 39

Similar Stocks

Discover high‑ranked alternatives to Astellas Pharma and broaden your portfolio horizons.

NGK Insulators

TYO:5333
Country: Japan
Industry: Industrial Machinery
Size: X-Large
Full Stock Analysis

Brother Industries

TYO:6448
Country: Japan
Industry: Technology Hardware & Peripherals
Size: X-Large
Full Stock Analysis

Shikoku Electric Power

TYO:9507
Country: Japan
Industry: Electric Utilities
Size: Large
Full Stock Analysis

transcosmos

TYO:9715
Country: Japan
Industry: Diversified Support Services
Size: Large
Full Stock Analysis

Frequently Asked
Questions

This is a high-quality, high-growth stock with positive sentiment. However, the financing is on the riskier side. It is best for a growth-focused investor willing to accept higher financial risk for potentially higher shareholder returns.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing: